社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
HUAT8
IP属地：未知
+关注
帖子 · 63
帖子 · 63
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
HUAT8
HUAT8
·
2021-11-15
Hope the bullish sentiment continues!
非常抱歉，此主贴已删除
看
1,669
回复
2
点赞
7
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-14
Yesss
Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?<blockquote>Meta Platforms本周收盘强劲：期权交易者的目标是历史高点吗？</blockquote>
Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off
Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?<blockquote>Meta Platforms本周收盘强劲：期权交易者的目标是历史高点吗？</blockquote>
看
1,760
回复
评论
点赞
4
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-12
👍
非常抱歉，此主贴已删除
看
1,846
回复
评论
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-09
[开心]
非常抱歉，此主贴已删除
看
1,996
回复
评论
点赞
4
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-05
Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考]
Bionano Genomics stock tanked more than 8% in premarket trading<blockquote>Bionano Genomics股价在盘前交易中下跌超过8%</blockquote>
Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $
Bionano Genomics stock tanked more than 8% in premarket trading<blockquote>Bionano Genomics股价在盘前交易中下跌超过8%</blockquote>
看
1,824
回复
1
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-04
To the 🌒
Fastly stock rallied 10% in premarket trading<blockquote>Fastly股价在盘前交易中上涨10%</blockquote>
Fastly stock is headed higher in premarket trading Thursday after the content delivery network and s
Fastly stock rallied 10% in premarket trading<blockquote>Fastly股价在盘前交易中上涨10%</blockquote>
看
1,940
回复
评论
点赞
1
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-04
👍
Tesla shares surged more than 2% to a new high in premarket trading<blockquote>特斯拉股价在盘前交易中飙升逾2%至新高</blockquote>
Tesla shares surged more than 2% to a new high in premarket trading.
Tesla shares surged more than 2% to a new high in premarket trading<blockquote>特斯拉股价在盘前交易中飙升逾2%至新高</blockquote>
看
2,732
回复
评论
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-03
Tonight is crucial
非常抱歉，此主贴已删除
看
1,990
回复
1
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-10-29
$ASML Holding NV(ASML)$
Rise rise
看
1,828
回复
评论
点赞
1
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-06-20
Next week let's see
非常抱歉，此主贴已删除
看
1,519
回复
评论
点赞
5
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3554811401768317","uuid":"3554811401768317","gmtCreate":1591858642071,"gmtModify":1615600810159,"name":"HUAT8","pinyin":"huat8","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":27,"headSize":136,"tweetSize":63,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":873626047,"gmtCreate":1636939567395,"gmtModify":1636939567549,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"Hope the bullish sentiment continues!","listText":"Hope the bullish sentiment continues!","text":"Hope the bullish sentiment continues!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873626047","repostId":"2183536049","repostType":4,"isVote":1,"tweetType":1,"viewCount":1669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873968058,"gmtCreate":1636845827862,"gmtModify":1636845832465,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"Yesss","listText":"Yesss","text":"Yesss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873968058","repostId":"1116750872","repostType":4,"repost":{"id":"1116750872","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1636761765,"share":"https://www.laohu8.com/m/news/1116750872?lang=zh_CN&edition=full","pubTime":"2021-11-13 08:02","market":"us","language":"en","title":"Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?<blockquote>Meta Platforms本周收盘强劲：期权交易者的目标是历史高点吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1116750872","media":"Benzinga","summary":"Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off","content":"<p><b>Meta Platforms Inc</b> is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.</p><p><blockquote><b>元平台公司</b>到目前为止，本周收盘强劲，上涨近3.5%，仅比周高点低7美元。</blockquote></p><p> <b>What Happened:</b> While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than 672,970 options with 476,002 being calls and 196,968 being puts. This comes out to about 7 out of every 10 options being calls (image below).</p><p><blockquote><b>发生了什么：</b>虽然股票交易量稳定在1700万股，而10天平均水平为2100万股，但期权交易者当天相当活跃，交易了超过672,970份期权，其中476,002份是评级期权，196,968份是看跌期权。这意味着每10个选项中就有7个是评级（如下图）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c08237f8d7c163047e56072f027073d5\" tg-width=\"1001\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>What It Matters:</b>Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000 options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.</p><p><blockquote><b>重要的是：</b>本周五之前，共有1,519,000份评级和1,207,750份看跌期权，期权总数为2,726,000份。因此，本周五的期权活动和流量为672,970笔，占期权总流量的25%。</blockquote></p><p> Any time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.</p><p><blockquote>股票在一天内交易总期权的25%时，这意味着期权交易商对股票尤为活跃。</blockquote></p><p> Of note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970 options suggest a lot more forward-looking flows.</p><p><blockquote>值得注意的是，只有11%的期权将于本周五到期（约300,000份期权），因此今天的672,970份期权表明了更多的前瞻性流动。</blockquote></p><p> <b>What's Next:</b>Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).</p><p><blockquote><b>下一步是什么：</b>看看下周11月19日到期的期权流，您可以看到看涨期权方面的大部分成交量和未平仓合约在330美元至360美元之间。在看跌方面，在340美元和300美元之间有一个持续但较小的成交量（如下图）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e74f74fdf39ce74de7e0d6a88eb349c8\" tg-width=\"1743\" tg-height=\"650\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> This suggests bullish traders are targeting between $330 and $360, but don't have much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.</p><p><blockquote>这表明看涨交易者的目标在330美元至360美元之间，但对此没有太大兴趣。与此同时，看跌期权交易者认为300美元以下不会有太大下行空间。</blockquote></p><p> It should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.</p><p><blockquote>应该指出的是，从340美元到300美元的稳定看跌期权交易量似乎是看涨交易者出售现金担保看跌期权至322.5美元的组合，但多头股票交易者可能会寻求低于该水平的保护，因为溢价非常低。</blockquote></p><p> Hence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.</p><p><blockquote>因此，看涨交易者希望看到360美元的罢工在下周之前被清除，以提高他们的预期，而空头则希望看到每周收盘价低于300美元以打开下行空间。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?<blockquote>Meta Platforms本周收盘强劲：期权交易者的目标是历史高点吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?<blockquote>Meta Platforms本周收盘强劲：期权交易者的目标是历史高点吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-11-13 08:02</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Meta Platforms Inc</b> is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.</p><p><blockquote><b>元平台公司</b>到目前为止，本周收盘强劲，上涨近3.5%，仅比周高点低7美元。</blockquote></p><p> <b>What Happened:</b> While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than 672,970 options with 476,002 being calls and 196,968 being puts. This comes out to about 7 out of every 10 options being calls (image below).</p><p><blockquote><b>发生了什么：</b>虽然股票交易量稳定在1700万股，而10天平均水平为2100万股，但期权交易者当天相当活跃，交易了超过672,970份期权，其中476,002份是评级期权，196,968份是看跌期权。这意味着每10个选项中就有7个是评级（如下图）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c08237f8d7c163047e56072f027073d5\" tg-width=\"1001\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>What It Matters:</b>Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000 options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.</p><p><blockquote><b>重要的是：</b>本周五之前，共有1,519,000份评级和1,207,750份看跌期权，期权总数为2,726,000份。因此，本周五的期权活动和流量为672,970笔，占期权总流量的25%。</blockquote></p><p> Any time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.</p><p><blockquote>股票在一天内交易总期权的25%时，这意味着期权交易商对股票尤为活跃。</blockquote></p><p> Of note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970 options suggest a lot more forward-looking flows.</p><p><blockquote>值得注意的是，只有11%的期权将于本周五到期（约300,000份期权），因此今天的672,970份期权表明了更多的前瞻性流动。</blockquote></p><p> <b>What's Next:</b>Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).</p><p><blockquote><b>下一步是什么：</b>看看下周11月19日到期的期权流，您可以看到看涨期权方面的大部分成交量和未平仓合约在330美元至360美元之间。在看跌方面，在340美元和300美元之间有一个持续但较小的成交量（如下图）。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e74f74fdf39ce74de7e0d6a88eb349c8\" tg-width=\"1743\" tg-height=\"650\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> This suggests bullish traders are targeting between $330 and $360, but don't have much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.</p><p><blockquote>这表明看涨交易者的目标在330美元至360美元之间，但对此没有太大兴趣。与此同时，看跌期权交易者认为300美元以下不会有太大下行空间。</blockquote></p><p> It should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.</p><p><blockquote>应该指出的是，从340美元到300美元的稳定看跌期权交易量似乎是看涨交易者出售现金担保看跌期权至322.5美元的组合，但多头股票交易者可能会寻求低于该水平的保护，因为溢价非常低。</blockquote></p><p> Hence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.</p><p><blockquote>因此，看涨交易者希望看到360美元的罢工在下周之前被清除，以提高他们的预期，而空头则希望看到每周收盘价低于300美元以打开下行空间。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FB":"ProShares S&P 500 Dynamic Buffer ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116750872","content_text":"Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.\nWhat Happened: While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than 672,970 options with 476,002 being calls and 196,968 being puts. This comes out to about 7 out of every 10 options being calls (image below).\n\nWhat It Matters:Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000 options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.\nAny time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.\nOf note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970 options suggest a lot more forward-looking flows.\nWhat's Next:Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).\n\nThis suggests bullish traders are targeting between $330 and $360, but don't have much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.\nIt should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.\nHence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.","news_type":1,"symbols_score_info":{"FB":0.9}},"isVote":1,"tweetType":1,"viewCount":1760,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879659570,"gmtCreate":1636720902837,"gmtModify":1636720906103,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879659570","repostId":"1138291710","repostType":4,"isVote":1,"tweetType":1,"viewCount":1846,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844679791,"gmtCreate":1636425761800,"gmtModify":1636425762185,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"[开心] ","listText":"[开心] ","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844679791","repostId":"1197954926","repostType":4,"isVote":1,"tweetType":1,"viewCount":1996,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846490504,"gmtCreate":1636102064007,"gmtModify":1636102064122,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考] ","listText":"Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考] ","text":"Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846490504","repostId":"1194946622","repostType":2,"repost":{"id":"1194946622","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636101187,"share":"https://www.laohu8.com/m/news/1194946622?lang=zh_CN&edition=full","pubTime":"2021-11-05 16:33","market":"us","language":"en","title":"Bionano Genomics stock tanked more than 8% in premarket trading<blockquote>Bionano Genomics股价在盘前交易中下跌超过8%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1194946622","media":"Tiger Newspress","summary":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $","content":"<p>Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p><p><blockquote>Bionano Genomics第三季度净亏损2075.3万美元，销售额466万美元，超出预期423万美元，Bionano Genomics股价在盘前交易中下跌超过8%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>Bionano Genomics, Inc.</b> reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.</p><p><blockquote><b>生物纳米基因组学公司。</b>报告了截至2021年9月30日的季度财务业绩和业务成就，并重点介绍了最近的公司更新。</blockquote></p><p> <i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p><p><blockquote><i>-收购BioDiscovery将Bionano从结构变异公司转变为数据解决方案提供商，有潜力提供基因组学领域最全面的变异分析平台</i></blockquote></p><p> <i>– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p><p><blockquote><i>-在Saphyr增长的推动下，总收入为470万美元，总收入同比增长112%®已安装底座</i></blockquote></p><p> <i>– Record number of Saphyr shipments and installations for any quarter to date</i></p><p><blockquote><i>-迄今为止任何季度Saphyr发货和安装数量均创历史新高</i></blockquote></p><p> <i>– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p><p><blockquote><i>-推出用于产前应用的羊膜穿刺术和绒毛取样(CVS)中超高分子量DNA分离方案</i></blockquote></p><p> <i>– Remaining 2021 milestones on track</i></p><p><blockquote><i>-2021年剩余里程碑步入正轨</i></blockquote></p><p> <i>– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021</i></p><p><blockquote><i>-截至2021年9月30日，资产负债表强劲，现金和短期投资为3.261亿美元</i></blockquote></p><p> “We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p><p><blockquote>“我们经历了Bionano历史上最强劲的季度，Saphyr的出货量和安装量创历史新高，包括在几个著名地点的采用，包括世界各地的领先医院、细胞遗传学实验室和学术医疗中心。随着收购BioDiscovery，这是一家领先的软件公司，为基因组学数据的分析、可视化、解释和报告提供一流的解决方案。对于微阵列和下一代测序(NGS)，我们正在将Bionano Genomics从结构变异公司转变为数据解决方案提供商。我们相信，这将通过软件利用NGS市场来扩大市场机会。我们对我们所取得的进展以及杰出的领导者加入Bionano与我们一起改变世界看待基因组的方式感到非常高兴。”Bionano Genomics首席执行官Derik Holmlin博士评论道。</blockquote></p><p> Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p><p><blockquote>Bionano首席财务官克里斯·斯图尔特补充说：“第三季度是另一个出色的季度。我们继续实现收入同比有意义的增长，截至本季度末，我们保持着3.26亿美元现金和有价证券的强劲资产负债表。我们还继续实现我们在2021年第一季度制定的里程碑。”</blockquote></p><p> <b>Key Business Highlights in Q3</b></p><p><blockquote><b>第三季度主要业务亮点</b></blockquote></p><p> The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p><p><blockquote>该公司执行其商业化战略，通过在关键科学会议上展示数据来建立科学势头，并推动全球关键机构对Saphyr的利用，重点如下：</blockquote></p><p> –<b> Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p><p><blockquote>–<b>将Saphyr系统的安装数量从第二季度末的121个扩大到第三季度末的141个</b>截至2021年9月30日的季度，我们总共向现场运送了24套Saphyr系统，而2020年同季度运送了11套系统。</blockquote></p><p> –<b> Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p><p><blockquote>–<b>截至2021年9月30日的季度售出3,969个纳米通道阵列流通池，</b>这是有史以来任何季度销售最多的流动池，比2020年同季度增长了122%。</blockquote></p><p> –<b> Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p><p><blockquote>–<b>用于产前应用的超高分子量DNA分离溶液的商业化发布</b>支持使用来自羊膜穿刺术和CVS的样本。Bionano Prep SP羊膜和CVS培养DNA分离方案支持新鲜培养物和冷冻保存细胞，这扩大了OGM的市场。</blockquote></p><p> – <b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p><p><blockquote>– <b>几个著名的细胞遗传学实验室和学术医学中心采用了带有Saphyr的OGM</b>在美国，包括布莱根妇女医院，该医院正在使用OGM来识别体质和癌症应用中的结构变异。在美国以外，Saphyr被澳大利亚、欧洲和中国采用。</blockquote></p><p> –<b> The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p><p><blockquote>–<b>迄今为止评估OGM的最大临床研究发表于</b><b><i>分子诊断学杂志</i></b>一种罕见的肌肉疾病，面肩肱肌营养不良症，或FSHD，在大约351名患者中。结果表明，与目前的Southern印迹分析的金标准方法相比，OGM提供的数据更快、更准确、更可重复。这些发现支持采用OGM作为Southern印迹分析的替代方案的基本原理，因为OGM具有更高的尺寸准确性以及与Southern印迹分析大于99%的一致性。</blockquote></p><p> –<b> NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p><p><blockquote>–<b>全球分子诊断领导者NuProbe Global采用Saphyr集成其专有工具，</b>定量扩增子测序（QASeq）和阻断剂置换扩增（BDA），用于生殖健康和肿瘤液体活检的研发工作。</blockquote></p><p></p><p> –<b> Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p><p><blockquote>–<b>Saphyr客户和Bionano在2021年8月中旬的年度癌症基因组学联盟会议上进行了10场演讲，</b>强调OGM在实体瘤分析、血液恶性肿瘤、受孕产物、产前和产后体质遗传学等临床研究应用中的益处。来自全球各地的500多名参与者以虚拟方式参加了会议，凸显了OGM对癌症基因组学的浓厚兴趣。</blockquote></p><p> – <b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p><p><blockquote>– <b>Bionano客户在2021年8月下旬的欧洲人类遗传学会(ESHG)会议上发表了11篇有关OGM的演讲</b>，展示了OGM在许多治疗应用领域的临床实用性，以及Bionano的Saphyr的独特能力®以相对于传统技术更高的分辨率检测整个基因组中所有类别的结构变异的系统。</blockquote></p><p> – <b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p><p><blockquote>– <b>增加了跨商业领导职能的杰出人才，</b>包括全球客户体验副总裁Amanda Lettmannas、战略产品营销副总裁Alex Helmas、企业营销副总裁Stephanie Hoyleas、全球销售培训和发展副总裁Amanda Hernandezas、Lineagen副总裁兼总经理Justin Leightonas和Bob Hertsenbergas北美销售总监。</blockquote></p><p> <b>Financial Highlights</b></p><p><blockquote><b>财务摘要</b></blockquote></p><p> –<b> Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p><p><blockquote>–<b>2021年第三季度总收入为470万美元，</b>比第二季度的390万美元增长21%，比2020年同期的220万美元增长112%。环比增长是由对我们的Saphyr光学基因组图谱解决方案的需求增加推动的，包括仪器销售的增加以及对我们的试剂租赁计划和消耗品的更大需求。同比增长是由产品销量增加和Lineagen收入增加推动的。</blockquote></p><p> –<b> Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p><p><blockquote>–<b>2021年第三季度毛利率为24.8%，</b>相比之下，上一季度为37.3%，2020年第三季度为33.4%。这一下降主要是由于实验室和保修相关费用的增加，预计这些费用将是非经常性的。</blockquote></p><p> –<b> Third quarter operating expense was$21.8 million,</b>compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p><p><blockquote>–<b>第三季度运营费用为2180万美元，</b>相比之下，上一季度为1790万美元，2020年第三季度为1100万美元。环比增长主要是由于员工人数和相关费用增加了180万美元，以及与扩大供应链以提高产量相关的研发费用增加了150万美元。第三季度运营费用包括280万美元的非现金股票薪酬。同比增长主要是由于我们构建组织的各个方面以支持我们预期的商业进展以及研发成本的增加，因此与员工相关的支出增加。</blockquote></p><p> – <b>AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p><p><blockquote>– <b>截至2021年9月30日，公司拥有现金、现金等价物和短期投资3.261亿美元</b>相比之下，2020年12月31日的现金和现金等价物为3840万美元。现金增加主要是由于2021年第一季度完成的股权融资。</blockquote></p><p> <b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p><p><blockquote><b>2021年剩余预期里程碑-推动全球采用Saphyr的举措</b></blockquote></p><p> – 4Q21: Interim publication of results from pediatric clinical study</p><p><blockquote>-4 Q21：儿科临床研究结果的中期公布</blockquote></p><p> – 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p><p><blockquote>-4 Q 21：在我们的产前临床研究和儿科临床研究中，3个研究中心对LDT的验证</blockquote></p><p> – 4Q21: Initial prototype of next gen high throughput Saphyr</p><p><blockquote>-4Q21：下一代高通量Saphyr的初始原型</blockquote></p><p> – 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p><p><blockquote>-21年第四季度：达到150套系统的安装基础，较2020年底增长50%</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics stock tanked more than 8% in premarket trading<blockquote>Bionano Genomics股价在盘前交易中下跌超过8%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics stock tanked more than 8% in premarket trading<blockquote>Bionano Genomics股价在盘前交易中下跌超过8%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-05 16:33</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p><p><blockquote>Bionano Genomics第三季度净亏损2075.3万美元，销售额466万美元，超出预期423万美元，Bionano Genomics股价在盘前交易中下跌超过8%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>Bionano Genomics, Inc.</b> reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.</p><p><blockquote><b>生物纳米基因组学公司。</b>报告了截至2021年9月30日的季度财务业绩和业务成就，并重点介绍了最近的公司更新。</blockquote></p><p> <i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p><p><blockquote><i>-收购BioDiscovery将Bionano从结构变异公司转变为数据解决方案提供商，有潜力提供基因组学领域最全面的变异分析平台</i></blockquote></p><p> <i>– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p><p><blockquote><i>-在Saphyr增长的推动下，总收入为470万美元，总收入同比增长112%®已安装底座</i></blockquote></p><p> <i>– Record number of Saphyr shipments and installations for any quarter to date</i></p><p><blockquote><i>-迄今为止任何季度Saphyr发货和安装数量均创历史新高</i></blockquote></p><p> <i>– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p><p><blockquote><i>-推出用于产前应用的羊膜穿刺术和绒毛取样(CVS)中超高分子量DNA分离方案</i></blockquote></p><p> <i>– Remaining 2021 milestones on track</i></p><p><blockquote><i>-2021年剩余里程碑步入正轨</i></blockquote></p><p> <i>– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021</i></p><p><blockquote><i>-截至2021年9月30日，资产负债表强劲，现金和短期投资为3.261亿美元</i></blockquote></p><p> “We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p><p><blockquote>“我们经历了Bionano历史上最强劲的季度，Saphyr的出货量和安装量创历史新高，包括在几个著名地点的采用，包括世界各地的领先医院、细胞遗传学实验室和学术医疗中心。随着收购BioDiscovery，这是一家领先的软件公司，为基因组学数据的分析、可视化、解释和报告提供一流的解决方案。对于微阵列和下一代测序(NGS)，我们正在将Bionano Genomics从结构变异公司转变为数据解决方案提供商。我们相信，这将通过软件利用NGS市场来扩大市场机会。我们对我们所取得的进展以及杰出的领导者加入Bionano与我们一起改变世界看待基因组的方式感到非常高兴。”Bionano Genomics首席执行官Derik Holmlin博士评论道。</blockquote></p><p> Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p><p><blockquote>Bionano首席财务官克里斯·斯图尔特补充说：“第三季度是另一个出色的季度。我们继续实现收入同比有意义的增长，截至本季度末，我们保持着3.26亿美元现金和有价证券的强劲资产负债表。我们还继续实现我们在2021年第一季度制定的里程碑。”</blockquote></p><p> <b>Key Business Highlights in Q3</b></p><p><blockquote><b>第三季度主要业务亮点</b></blockquote></p><p> The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p><p><blockquote>该公司执行其商业化战略，通过在关键科学会议上展示数据来建立科学势头，并推动全球关键机构对Saphyr的利用，重点如下：</blockquote></p><p> –<b> Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p><p><blockquote>–<b>将Saphyr系统的安装数量从第二季度末的121个扩大到第三季度末的141个</b>截至2021年9月30日的季度，我们总共向现场运送了24套Saphyr系统，而2020年同季度运送了11套系统。</blockquote></p><p> –<b> Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p><p><blockquote>–<b>截至2021年9月30日的季度售出3,969个纳米通道阵列流通池，</b>这是有史以来任何季度销售最多的流动池，比2020年同季度增长了122%。</blockquote></p><p> –<b> Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p><p><blockquote>–<b>用于产前应用的超高分子量DNA分离溶液的商业化发布</b>支持使用来自羊膜穿刺术和CVS的样本。Bionano Prep SP羊膜和CVS培养DNA分离方案支持新鲜培养物和冷冻保存细胞，这扩大了OGM的市场。</blockquote></p><p> – <b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p><p><blockquote>– <b>几个著名的细胞遗传学实验室和学术医学中心采用了带有Saphyr的OGM</b>在美国，包括布莱根妇女医院，该医院正在使用OGM来识别体质和癌症应用中的结构变异。在美国以外，Saphyr被澳大利亚、欧洲和中国采用。</blockquote></p><p> –<b> The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p><p><blockquote>–<b>迄今为止评估OGM的最大临床研究发表于</b><b><i>分子诊断学杂志</i></b>一种罕见的肌肉疾病，面肩肱肌营养不良症，或FSHD，在大约351名患者中。结果表明，与目前的Southern印迹分析的金标准方法相比，OGM提供的数据更快、更准确、更可重复。这些发现支持采用OGM作为Southern印迹分析的替代方案的基本原理，因为OGM具有更高的尺寸准确性以及与Southern印迹分析大于99%的一致性。</blockquote></p><p> –<b> NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p><p><blockquote>–<b>全球分子诊断领导者NuProbe Global采用Saphyr集成其专有工具，</b>定量扩增子测序（QASeq）和阻断剂置换扩增（BDA），用于生殖健康和肿瘤液体活检的研发工作。</blockquote></p><p></p><p> –<b> Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p><p><blockquote>–<b>Saphyr客户和Bionano在2021年8月中旬的年度癌症基因组学联盟会议上进行了10场演讲，</b>强调OGM在实体瘤分析、血液恶性肿瘤、受孕产物、产前和产后体质遗传学等临床研究应用中的益处。来自全球各地的500多名参与者以虚拟方式参加了会议，凸显了OGM对癌症基因组学的浓厚兴趣。</blockquote></p><p> – <b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p><p><blockquote>– <b>Bionano客户在2021年8月下旬的欧洲人类遗传学会(ESHG)会议上发表了11篇有关OGM的演讲</b>，展示了OGM在许多治疗应用领域的临床实用性，以及Bionano的Saphyr的独特能力®以相对于传统技术更高的分辨率检测整个基因组中所有类别的结构变异的系统。</blockquote></p><p> – <b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p><p><blockquote>– <b>增加了跨商业领导职能的杰出人才，</b>包括全球客户体验副总裁Amanda Lettmannas、战略产品营销副总裁Alex Helmas、企业营销副总裁Stephanie Hoyleas、全球销售培训和发展副总裁Amanda Hernandezas、Lineagen副总裁兼总经理Justin Leightonas和Bob Hertsenbergas北美销售总监。</blockquote></p><p> <b>Financial Highlights</b></p><p><blockquote><b>财务摘要</b></blockquote></p><p> –<b> Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p><p><blockquote>–<b>2021年第三季度总收入为470万美元，</b>比第二季度的390万美元增长21%，比2020年同期的220万美元增长112%。环比增长是由对我们的Saphyr光学基因组图谱解决方案的需求增加推动的，包括仪器销售的增加以及对我们的试剂租赁计划和消耗品的更大需求。同比增长是由产品销量增加和Lineagen收入增加推动的。</blockquote></p><p> –<b> Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p><p><blockquote>–<b>2021年第三季度毛利率为24.8%，</b>相比之下，上一季度为37.3%，2020年第三季度为33.4%。这一下降主要是由于实验室和保修相关费用的增加，预计这些费用将是非经常性的。</blockquote></p><p> –<b> Third quarter operating expense was$21.8 million,</b>compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p><p><blockquote>–<b>第三季度运营费用为2180万美元，</b>相比之下，上一季度为1790万美元，2020年第三季度为1100万美元。环比增长主要是由于员工人数和相关费用增加了180万美元，以及与扩大供应链以提高产量相关的研发费用增加了150万美元。第三季度运营费用包括280万美元的非现金股票薪酬。同比增长主要是由于我们构建组织的各个方面以支持我们预期的商业进展以及研发成本的增加，因此与员工相关的支出增加。</blockquote></p><p> – <b>AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p><p><blockquote>– <b>截至2021年9月30日，公司拥有现金、现金等价物和短期投资3.261亿美元</b>相比之下，2020年12月31日的现金和现金等价物为3840万美元。现金增加主要是由于2021年第一季度完成的股权融资。</blockquote></p><p> <b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p><p><blockquote><b>2021年剩余预期里程碑-推动全球采用Saphyr的举措</b></blockquote></p><p> – 4Q21: Interim publication of results from pediatric clinical study</p><p><blockquote>-4 Q21：儿科临床研究结果的中期公布</blockquote></p><p> – 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p><p><blockquote>-4 Q 21：在我们的产前临床研究和儿科临床研究中，3个研究中心对LDT的验证</blockquote></p><p> – 4Q21: Initial prototype of next gen high throughput Saphyr</p><p><blockquote>-4Q21：下一代高通量Saphyr的初始原型</blockquote></p><p> – 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p><p><blockquote>-21年第四季度：达到150套系统的安装基础，较2020年底增长50%</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194946622","content_text":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.\n\nBionano Genomics, Inc. reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.\n– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics\n– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base\n– Record number of Saphyr shipments and installations for any quarter to date\n– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications\n– Remaining 2021 milestones on track\n– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021\n“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.\nChris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”\nKey Business Highlights in Q3\nThe Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:\n– Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.\n– Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.\n– Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applicationssupporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.\n– OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centersinthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.\n– The largest clinical research study to date evaluating OGM was published inThe Journal of Molecular Diagnosticsfor a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.\n– NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.\n– Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.\n– Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.\n– Added exceptional talent across commercial leadership functions,includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.\nFinancial Highlights\n– Total revenue for the third quarter of 2021 was$4.7 million,up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.\n– Gross margin for the third quarter of 2021 was 24.8%,compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.\n– Third quarter operating expense was$21.8 million,compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.\n– AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 millioncompared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.\nRemaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr\n– 4Q21: Interim publication of results from pediatric clinical study\n– 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study\n– 4Q21: Initial prototype of next gen high throughput Saphyr\n– 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020","news_type":1,"symbols_score_info":{"BNGO":0.9}},"isVote":1,"tweetType":1,"viewCount":1824,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848402569,"gmtCreate":1636016563543,"gmtModify":1636016564678,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"To the 🌒","listText":"To the 🌒","text":"To the 🌒","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848402569","repostId":"1144080729","repostType":4,"repost":{"id":"1144080729","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636013373,"share":"https://www.laohu8.com/m/news/1144080729?lang=zh_CN&edition=full","pubTime":"2021-11-04 16:09","market":"us","language":"en","title":"Fastly stock rallied 10% in premarket trading<blockquote>Fastly股价在盘前交易中上涨10%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144080729","media":"Tiger Newspress","summary":"Fastly stock is headed higher in premarket trading Thursday after the content delivery network and s","content":"<p>Fastly stock is headed higher in premarket trading Thursday after the content delivery network and security software company posted better-than-expected third-quarter results.</p><p><blockquote>内容交付网络和安全软件公司Fastly公布好于预期的第三季度业绩后，该公司股价周四在盘前交易中走高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ac59473a8ca3be4035f97c817c4808c2\" tg-width=\"850\" tg-height=\"621\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> For the quarter, Fastly posted revenue of $87 million, up 23% from a year earlier, and ahead of the Street consensus forecast of $83.7 million. On a non-GAAP basis, the company lost 11 cents a share, narrower than the Street consensus forecast for a loss of 19 cents a share.</p><p><blockquote>Fastly本季度营收为8700万美元，同比增长23%，高于华尔街普遍预测的8370万美元。按非公认会计准则计算，该公司每股亏损11美分，低于华尔街普遍预测的每股亏损19美分。</blockquote></p><p> Fastly said its enterprise customer count grew to 430 from 408 one quarter earlier, while the total customer count increased to 2,748 from 2,581.</p><p><blockquote>Fastly表示，其企业客户数量从一个季度前的408家增加到430家，而客户总数从2,581家增加到2,748家。</blockquote></p><p> The company noted that after a widely publicized network outage in the second quarter, some customers paused on using the platform. But CEO Joshua Bixby said in a letter to shareholders that the issue has been resolved and the customers are back. “I am pleased to report that our top customers have returned traffic and continue to ramp following significant stability and resilience work by our infrastructure and engineering teams,” he wrote.</p><p><blockquote>该公司指出，在第二季度广泛宣传的网络中断后，一些客户暂停使用该平台。但首席执行官约书亚·比克斯比(Joshua Bixby)在致股东的一封信中表示，问题已经解决，客户也回来了。他写道：“我很高兴地报告，经过我们的基础设施和工程团队的大量稳定性和弹性工作，我们的顶级客户已经恢复了流量，并继续增加。”</blockquote></p><p> For the December quarter, Fastly is projecting revenue of $90 million to $93 million, with a non-GAAP loss of 16 to 19 cents a share. Street consensus previously had called for revenue of $91.9 million and a loss of 15 cents a share.</p><p><blockquote>Fastly预计12月份季度的收入为9000万至9300万美元，非GAAP每股亏损为16至19美分。华尔街此前的共识是营收为9190万美元，每股亏损15美分。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fastly stock rallied 10% in premarket trading<blockquote>Fastly股价在盘前交易中上涨10%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFastly stock rallied 10% in premarket trading<blockquote>Fastly股价在盘前交易中上涨10%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-04 16:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Fastly stock is headed higher in premarket trading Thursday after the content delivery network and security software company posted better-than-expected third-quarter results.</p><p><blockquote>内容交付网络和安全软件公司Fastly公布好于预期的第三季度业绩后，该公司股价周四在盘前交易中走高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ac59473a8ca3be4035f97c817c4808c2\" tg-width=\"850\" tg-height=\"621\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> For the quarter, Fastly posted revenue of $87 million, up 23% from a year earlier, and ahead of the Street consensus forecast of $83.7 million. On a non-GAAP basis, the company lost 11 cents a share, narrower than the Street consensus forecast for a loss of 19 cents a share.</p><p><blockquote>Fastly本季度营收为8700万美元，同比增长23%，高于华尔街普遍预测的8370万美元。按非公认会计准则计算，该公司每股亏损11美分，低于华尔街普遍预测的每股亏损19美分。</blockquote></p><p> Fastly said its enterprise customer count grew to 430 from 408 one quarter earlier, while the total customer count increased to 2,748 from 2,581.</p><p><blockquote>Fastly表示，其企业客户数量从一个季度前的408家增加到430家，而客户总数从2,581家增加到2,748家。</blockquote></p><p> The company noted that after a widely publicized network outage in the second quarter, some customers paused on using the platform. But CEO Joshua Bixby said in a letter to shareholders that the issue has been resolved and the customers are back. “I am pleased to report that our top customers have returned traffic and continue to ramp following significant stability and resilience work by our infrastructure and engineering teams,” he wrote.</p><p><blockquote>该公司指出，在第二季度广泛宣传的网络中断后，一些客户暂停使用该平台。但首席执行官约书亚·比克斯比(Joshua Bixby)在致股东的一封信中表示，问题已经解决，客户也回来了。他写道：“我很高兴地报告，经过我们的基础设施和工程团队的大量稳定性和弹性工作，我们的顶级客户已经恢复了流量，并继续增加。”</blockquote></p><p> For the December quarter, Fastly is projecting revenue of $90 million to $93 million, with a non-GAAP loss of 16 to 19 cents a share. Street consensus previously had called for revenue of $91.9 million and a loss of 15 cents a share.</p><p><blockquote>Fastly预计12月份季度的收入为9000万至9300万美元，非GAAP每股亏损为16至19美分。华尔街此前的共识是营收为9190万美元，每股亏损15美分。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSLY":"Fastly, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144080729","content_text":"Fastly stock is headed higher in premarket trading Thursday after the content delivery network and security software company posted better-than-expected third-quarter results.\n\nFor the quarter, Fastly posted revenue of $87 million, up 23% from a year earlier, and ahead of the Street consensus forecast of $83.7 million. On a non-GAAP basis, the company lost 11 cents a share, narrower than the Street consensus forecast for a loss of 19 cents a share.\nFastly said its enterprise customer count grew to 430 from 408 one quarter earlier, while the total customer count increased to 2,748 from 2,581.\nThe company noted that after a widely publicized network outage in the second quarter, some customers paused on using the platform. But CEO Joshua Bixby said in a letter to shareholders that the issue has been resolved and the customers are back. “I am pleased to report that our top customers have returned traffic and continue to ramp following significant stability and resilience work by our infrastructure and engineering teams,” he wrote.\nFor the December quarter, Fastly is projecting revenue of $90 million to $93 million, with a non-GAAP loss of 16 to 19 cents a share. Street consensus previously had called for revenue of $91.9 million and a loss of 15 cents a share.","news_type":1,"symbols_score_info":{"FSLY":0.9}},"isVote":1,"tweetType":1,"viewCount":1940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848402147,"gmtCreate":1636016534044,"gmtModify":1636016556323,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848402147","repostId":"1184547180","repostType":4,"repost":{"id":"1184547180","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636013921,"share":"https://www.laohu8.com/m/news/1184547180?lang=zh_CN&edition=full","pubTime":"2021-11-04 16:18","market":"us","language":"en","title":"Tesla shares surged more than 2% to a new high in premarket trading<blockquote>特斯拉股价在盘前交易中飙升逾2%至新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1184547180","media":"Tiger Newspress","summary":"Tesla shares surged more than 2% to a new high in premarket trading.","content":"<p>Tesla shares surged more than 2% to a new high in premarket trading.</p><p><blockquote>特斯拉股价在盘前交易中飙升逾2%，创下新高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e3a05912968b722506b7360bb563f229\" tg-width=\"850\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla shares surged more than 2% to a new high in premarket trading<blockquote>特斯拉股价在盘前交易中飙升逾2%至新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla shares surged more than 2% to a new high in premarket trading<blockquote>特斯拉股价在盘前交易中飙升逾2%至新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-04 16:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla shares surged more than 2% to a new high in premarket trading.</p><p><blockquote>特斯拉股价在盘前交易中飙升逾2%，创下新高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e3a05912968b722506b7360bb563f229\" tg-width=\"850\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184547180","content_text":"Tesla shares surged more than 2% to a new high in premarket trading.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":2732,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841172174,"gmtCreate":1635898741641,"gmtModify":1635898741796,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"Tonight is crucial","listText":"Tonight is crucial","text":"Tonight is crucial","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841172174","repostId":"2180736486","repostType":4,"isVote":1,"tweetType":1,"viewCount":1990,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857046854,"gmtCreate":1635498736986,"gmtModify":1635498984025,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASML\">$ASML Holding NV(ASML)$</a>Rise rise","listText":"<a href=\"https://laohu8.com/S/ASML\">$ASML Holding NV(ASML)$</a>Rise rise","text":"$ASML Holding NV(ASML)$Rise rise","images":[{"img":"https://static.tigerbbs.com/9ff540605abf19a5c0f68ec5ec6a1970","width":"1080","height":"3362"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857046854","isVote":1,"tweetType":1,"viewCount":1828,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":165577747,"gmtCreate":1624153861589,"gmtModify":1634010237799,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3554811401768317","idStr":"3554811401768317"},"themes":[],"htmlText":"Next week let's see","listText":"Next week let's see","text":"Next week let's see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165577747","repostId":"1126454279","repostType":4,"isVote":1,"tweetType":1,"viewCount":1519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}